TriSalus Life Sciences, Inc. (TLSI)
4.985
-0.16
(-3.02%)
USD |
NASDAQ |
Sep 03, 16:00
4.985
0.00 (0.00%)
After-Hours: 20:00
TriSalus Life Sciences Price : 4.985 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 5.18 | 5.37 | 5.016 | 5.14 | 250642.0 |
| Sep 01, 2026 | 4.96 | 5.23 | 4.935 | 5.17 | 82574.00 |
| Aug 31, 2026 | 4.85 | 5.025 | 4.81 | 4.95 | 72687.00 |
| Aug 28, 2026 | 4.94 | 5.240 | 4.700 | 4.83 | 79975.00 |
| Aug 27, 2026 | 4.90 | 5.11 | 4.72 | 4.93 | 74622.00 |
| Aug 26, 2026 | 5.04 | 5.04 | 4.815 | 4.93 | 92307.00 |
| Aug 25, 2026 | 5.10 | 5.26 | 4.965 | 5.03 | 174795.0 |
| Aug 24, 2026 | 5.30 | 5.30 | 5.03 | 5.11 | 86911.00 |
| Aug 21, 2026 | 5.21 | 5.35 | 5.18 | 5.27 | 98694.00 |
| Aug 20, 2026 | 5.43 | 5.43 | 5.22 | 5.23 | 74977.00 |
| Aug 19, 2026 | 5.47 | 5.57 | 5.36 | 5.49 | 178249.0 |
| Aug 18, 2026 | 5.20 | 5.505 | 5.19 | 5.40 | 118942.0 |
| Aug 17, 2026 | 5.23 | 5.445 | 5.18 | 5.27 | 93670.00 |
| Aug 14, 2026 | 5.59 | 5.635 | 5.24 | 5.27 | 113804.0 |
| Aug 13, 2026 | 5.74 | 5.91 | 5.57 | 5.63 | 268074.0 |
| Aug 12, 2026 | 5.74 | 5.82 | 5.52 | 5.71 | 141062.0 |
| Aug 11, 2026 | 5.53 | 5.85 | 5.42 | 5.74 | 252189.0 |
| Aug 10, 2026 | 5.49 | 5.65 | 5.23 | 5.58 | 285690.0 |
| Aug 07, 2026 | 4.94 | 5.756 | 4.672 | 5.61 | 700850.0 |
| Aug 06, 2026 | 4.67 | 4.93 | 4.62 | 4.87 | 203821.0 |
| Aug 05, 2026 | 4.76 | 4.78 | 4.44 | 4.62 | 290215.0 |
| Aug 04, 2026 | 4.78 | 4.89 | 4.61 | 4.74 | 357473.0 |
| Aug 03, 2026 | 4.51 | 4.79 | 4.444 | 4.75 | 135156.0 |
| Jul 31, 2026 | 4.55 | 4.59 | 4.38 | 4.54 | 190521.0 |
| Jul 30, 2026 | 4.38 | 4.58 | 4.29 | 4.56 | 113134.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.86 |
| Alnylam Pharmaceuticals, Inc. | 264.16 |
| Anika Therapeutics, Inc. | 21.01 |
| Savara, Inc. | 5.36 |
| Vericel Corp. | 40.52 |
Price Related Metrics
| PS Ratio | 5.544 |
| PEG Ratio | -0.3887 |
| Price to Book Value | 46.78 |
| Earnings Yield | -25.98% |
| Market Cap | 306.43M |
| PEGY Ratio | -0.3887 |